Cortalix at Nordic Life Science Days 2025 in Gothenburg

Cortalix is pleased to announce that we will be attending Nordic Life Science Days (NLSDays) 2025, which takes place on 13–14 October in Gothenburg, Sweden. NLSDays is the leading partnering conference for the life sciences sector in Northern Europe, bringing together biotech and pharmaceutical companies, CROs, and investors to discuss innovation, partnerships, and future opportunities.

For Cortalix, this event provides an ideal stage to present our expertise in VHH antibody discovery and engineering. Our proprietary nanobody platforms are designed to accelerate development across multiple application areas, including radiopharmaceuticals for cancer treatment and imaging, CAR-T cell immunotherapy, and next-generation diagnostics such as molecular imaging probes and high-sensitivity immunoassays.

VHH antibodies (nanobodies) have emerged as a proven and versatile therapeutic and diagnostic format, with over 100 programs already in clinical development or on the market. Their unique properties (small size, high stability, and ability to reach cryptic or otherwise “undruggable” targets) make them powerful tools for the next generation of medicines and diagnostics.

During NLSDays, our team will be available to meet with companies and collaborators interested in exploring the potential of VHH antibody technology. Whether you are looking for a partner in discovery, engineering, or application development, Cortalix offers flexible collaboration models to help move projects forward.

If you are attending NLSDays in Gothenburg, we would be delighted to connect. Please contact us to schedule a meeting in advance, or visit us during the conference. We look forward to discussing the latest developments in VHH antibodies and to exploring new collaborations that will drive innovation in life sciences.

​Let’s meet in Gothenburg!

For more information about Cortalix: www.cortalix.com

Contact

For Cortalix:
Herman Steen, PhD
CEO Cortalix BV
info@cortalix.com